Shijiazhuang Kangli Pharmaceutical

Shijiazhuang Kangli Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates multiple GMP-certified production lines and focuses on a broad portfolio of generic medications, including antibiotics, analgesics, and cardiovascular treatments. Kangli Pharmaceutical serves both the domestic Chinese market and international clients through its contract manufacturing and export operations. Its business model is centered on providing high-quality, cost-effective chemical drugs and intermediates to the global healthcare industry.